Surgical experience of cardiac tumors: Early and late results

Noriyoshi Kajihara, Yoshihisa Tanoue, Masataka Eto, Yukihiro Tomita, Munetaka Masuda, Shigeki Morita

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Purpose. Cardiac tumors include benign and malignant neoplasms that arise within the cardiac chambers or myocardium. This study summarizes our surgical experiences with cardiac tumors. Methods. Between 1975 and 2003, 51 patients with cardiac tumors were surgically treated. Results. Myxomas. Forty-seven cardiac myxomas were excised in 46 patients with an average age of 51.7 ± 18 years. The preoperative symptoms included congestive heart failure (37%) and embolism (30%). The incidence of preoperative embolization was significantly higher in the gelatinous and lobated myxomas than in the solid and smooth form (P = 0.017). The early mortality rate was 2.2%. Although the late mortality rate was 9.7%, no patients died from cardiological causes (mean follow-up, 11.2 years). Only 1 patient required surgery for recurrence. Benign nonmyxomatous tumors. Three patients with a mean age of 26.3 ± 19.0 years showed benign nonmyxomatous tumors. There were no perioperative or late deaths. Malignant tumors. Two patients were diagnosed to have malignant tumors and although there was no perioperative death, both died postoperatively within 6 months. Conclusions. Cardiac myxomas and nonmyxomatous benign cardiac tumors show excellent results after a surgical excision, with a low morbidity and mortality. A surgical resection should thus be considered as a treatment option for patients with malignant tumors.

Original languageEnglish
Pages (from-to)602-607
Number of pages6
JournalSurgery today
Volume36
Issue number7
DOIs
Publication statusPublished - Jul 1 2006

Fingerprint

Heart Neoplasms
Myxoma
Neoplasms
Mortality
Embolism
Myocardium
Heart Failure
Morbidity
Recurrence
Incidence

All Science Journal Classification (ASJC) codes

  • Surgery

Cite this

Kajihara, N., Tanoue, Y., Eto, M., Tomita, Y., Masuda, M., & Morita, S. (2006). Surgical experience of cardiac tumors: Early and late results. Surgery today, 36(7), 602-607. https://doi.org/10.1007/s00595-006-3217-6

Surgical experience of cardiac tumors : Early and late results. / Kajihara, Noriyoshi; Tanoue, Yoshihisa; Eto, Masataka; Tomita, Yukihiro; Masuda, Munetaka; Morita, Shigeki.

In: Surgery today, Vol. 36, No. 7, 01.07.2006, p. 602-607.

Research output: Contribution to journalArticle

Kajihara, N, Tanoue, Y, Eto, M, Tomita, Y, Masuda, M & Morita, S 2006, 'Surgical experience of cardiac tumors: Early and late results', Surgery today, vol. 36, no. 7, pp. 602-607. https://doi.org/10.1007/s00595-006-3217-6
Kajihara, Noriyoshi ; Tanoue, Yoshihisa ; Eto, Masataka ; Tomita, Yukihiro ; Masuda, Munetaka ; Morita, Shigeki. / Surgical experience of cardiac tumors : Early and late results. In: Surgery today. 2006 ; Vol. 36, No. 7. pp. 602-607.
@article{e7660a08da834b9ba2ca2440dd76a90f,
title = "Surgical experience of cardiac tumors: Early and late results",
abstract = "Purpose. Cardiac tumors include benign and malignant neoplasms that arise within the cardiac chambers or myocardium. This study summarizes our surgical experiences with cardiac tumors. Methods. Between 1975 and 2003, 51 patients with cardiac tumors were surgically treated. Results. Myxomas. Forty-seven cardiac myxomas were excised in 46 patients with an average age of 51.7 ± 18 years. The preoperative symptoms included congestive heart failure (37{\%}) and embolism (30{\%}). The incidence of preoperative embolization was significantly higher in the gelatinous and lobated myxomas than in the solid and smooth form (P = 0.017). The early mortality rate was 2.2{\%}. Although the late mortality rate was 9.7{\%}, no patients died from cardiological causes (mean follow-up, 11.2 years). Only 1 patient required surgery for recurrence. Benign nonmyxomatous tumors. Three patients with a mean age of 26.3 ± 19.0 years showed benign nonmyxomatous tumors. There were no perioperative or late deaths. Malignant tumors. Two patients were diagnosed to have malignant tumors and although there was no perioperative death, both died postoperatively within 6 months. Conclusions. Cardiac myxomas and nonmyxomatous benign cardiac tumors show excellent results after a surgical excision, with a low morbidity and mortality. A surgical resection should thus be considered as a treatment option for patients with malignant tumors.",
author = "Noriyoshi Kajihara and Yoshihisa Tanoue and Masataka Eto and Yukihiro Tomita and Munetaka Masuda and Shigeki Morita",
year = "2006",
month = "7",
day = "1",
doi = "10.1007/s00595-006-3217-6",
language = "English",
volume = "36",
pages = "602--607",
journal = "Surgery Today",
issn = "0941-1291",
publisher = "Springer Japan",
number = "7",

}

TY - JOUR

T1 - Surgical experience of cardiac tumors

T2 - Early and late results

AU - Kajihara, Noriyoshi

AU - Tanoue, Yoshihisa

AU - Eto, Masataka

AU - Tomita, Yukihiro

AU - Masuda, Munetaka

AU - Morita, Shigeki

PY - 2006/7/1

Y1 - 2006/7/1

N2 - Purpose. Cardiac tumors include benign and malignant neoplasms that arise within the cardiac chambers or myocardium. This study summarizes our surgical experiences with cardiac tumors. Methods. Between 1975 and 2003, 51 patients with cardiac tumors were surgically treated. Results. Myxomas. Forty-seven cardiac myxomas were excised in 46 patients with an average age of 51.7 ± 18 years. The preoperative symptoms included congestive heart failure (37%) and embolism (30%). The incidence of preoperative embolization was significantly higher in the gelatinous and lobated myxomas than in the solid and smooth form (P = 0.017). The early mortality rate was 2.2%. Although the late mortality rate was 9.7%, no patients died from cardiological causes (mean follow-up, 11.2 years). Only 1 patient required surgery for recurrence. Benign nonmyxomatous tumors. Three patients with a mean age of 26.3 ± 19.0 years showed benign nonmyxomatous tumors. There were no perioperative or late deaths. Malignant tumors. Two patients were diagnosed to have malignant tumors and although there was no perioperative death, both died postoperatively within 6 months. Conclusions. Cardiac myxomas and nonmyxomatous benign cardiac tumors show excellent results after a surgical excision, with a low morbidity and mortality. A surgical resection should thus be considered as a treatment option for patients with malignant tumors.

AB - Purpose. Cardiac tumors include benign and malignant neoplasms that arise within the cardiac chambers or myocardium. This study summarizes our surgical experiences with cardiac tumors. Methods. Between 1975 and 2003, 51 patients with cardiac tumors were surgically treated. Results. Myxomas. Forty-seven cardiac myxomas were excised in 46 patients with an average age of 51.7 ± 18 years. The preoperative symptoms included congestive heart failure (37%) and embolism (30%). The incidence of preoperative embolization was significantly higher in the gelatinous and lobated myxomas than in the solid and smooth form (P = 0.017). The early mortality rate was 2.2%. Although the late mortality rate was 9.7%, no patients died from cardiological causes (mean follow-up, 11.2 years). Only 1 patient required surgery for recurrence. Benign nonmyxomatous tumors. Three patients with a mean age of 26.3 ± 19.0 years showed benign nonmyxomatous tumors. There were no perioperative or late deaths. Malignant tumors. Two patients were diagnosed to have malignant tumors and although there was no perioperative death, both died postoperatively within 6 months. Conclusions. Cardiac myxomas and nonmyxomatous benign cardiac tumors show excellent results after a surgical excision, with a low morbidity and mortality. A surgical resection should thus be considered as a treatment option for patients with malignant tumors.

UR - http://www.scopus.com/inward/record.url?scp=33745489153&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745489153&partnerID=8YFLogxK

U2 - 10.1007/s00595-006-3217-6

DO - 10.1007/s00595-006-3217-6

M3 - Article

C2 - 16794794

AN - SCOPUS:33745489153

VL - 36

SP - 602

EP - 607

JO - Surgery Today

JF - Surgery Today

SN - 0941-1291

IS - 7

ER -